CLINICAL TRIALS PROFILE FOR OXANDRIN
✉ Email this page to a colleague
All Clinical Trials for OXANDRIN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00070148 ↗ | Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 2004-03-01 | RATIONALE: Oxandrolone and megestrol may help prevent weight loss and improve quality of life in patients with cancer. It is not yet known whether oxandrolone is more effective than megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors. PURPOSE: This randomized phase III trial is studying oxandrolone to see how well it works compared to megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors. |
| NCT00070148 ↗ | Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer | Completed | Wake Forest NCORP Research Base | Phase 3 | 2004-03-01 | RATIONALE: Oxandrolone and megestrol may help prevent weight loss and improve quality of life in patients with cancer. It is not yet known whether oxandrolone is more effective than megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors. PURPOSE: This randomized phase III trial is studying oxandrolone to see how well it works compared to megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors. |
| NCT00070148 ↗ | Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer | Completed | Wake Forest University Health Sciences | Phase 3 | 2004-03-01 | RATIONALE: Oxandrolone and megestrol may help prevent weight loss and improve quality of life in patients with cancer. It is not yet known whether oxandrolone is more effective than megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors. PURPOSE: This randomized phase III trial is studying oxandrolone to see how well it works compared to megestrol in preventing weight loss and improving quality of life in patients who are receiving chemotherapy for solid tumors. |
| NCT00243399 ↗ | Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia | Completed | FDA Office of Orphan Products Development | Phase 1 | 2004-07-01 | The purpose of this study is to evaluate the safety of the drug oxandrolone (a type of androgen steroid) in patients with Fanconi anemia (FA), and to determine if this drug can help in the treatment of bone marrow failure in these patients. Androgen steroids are male hormones that can stimulate the production of red blood cells (the cells which carry oxygen in the blood) and platelets (cells that help blood clot). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OXANDRIN
Condition Name
| Condition Name for OXANDRIN | |
| Intervention | Trials |
| Hypoplastic Left Heart | 1 |
| To Determine the Bioequivalence Under Fasting Conditions | 1 |
| Unspecified Adult Solid Tumor, Protocol Specific | 1 |
| Weight Changes | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for OXANDRIN
Trials by Country
Clinical Trial Progress for OXANDRIN
Clinical Trial Phase
Clinical Trial Sponsors for OXANDRIN
Sponsor Name
